Results for tag: "Invokana"

Invokana is a prescription medication used to treat type 2 diabetes, a chronic endocrine and metabolic disorder. It belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by blocking the reabsorption of glucose by the kidneys, allowing it to be eliminated in the urine. Invokana is taken orally once a day and is typically used in combination with diet and exercise to improve glycemic control. It is also used to reduce the risk of cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. Invokana is marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Other companies in the market include AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, and Sanofi. Show Less Read more